Minimally Invasive Surgical Strategies for Alveolar Echinococcosis of the Liver.

BACKGROUND

Alveolar echinococcosis (AE) is a significant health concern worldwide, primarily affecting the liver. The standard treatment of surgical removal faces significant challenges due to the complex nature of AE. Despite advancements in pharmacological treatments, surgery complemented by at least 2 years of adjuvant medical treatment post-surgery remains the primary curative approach for AE.

SUMMARY

The introduction of minimally invasive techniques, such as laparoscopic and robot-assisted surgery, has expanded surgical options, offering reduced recovery times and minimized surgical trauma while maintaining efficacy and safety comparable to traditional open surgery. Robotic surgery, known for its enhanced precision and visualization, emerges as a preferable method for complex resections in AE treatment, despite challenges such as high costs and the need for specialized training.

KEY MESSAGES

The decision on the surgical approach is influenced by several factors, including parasite size, patient health, and technology availability. However, there is a clear preference for robotic procedures for their potential to offer better outcomes, though long-term data on outcomes and recurrence rates are needed. The treatment of AE, therefore, underscores the importance of an interdisciplinary approach and the advantages of minimally invasive surgery, advocating for its application in high-volume centers to optimize patient outcomes.